Figure 2.
Assessment of the Risk of Bias in Modified Rob-2 Crossover Randomized Clinical Trials. The domains presented: D1: Biases arising from the randomization process; DS: Biases arising from the period and effects of travel; D2: Bias caused by deviation from the planned intervention; D3: Bias due to missing outcome data; D4: Bias in outcome measurement; D5: Bias in the selection of reported results [15,16,17,26].